![]() |
|
|
Vol. 290, Issue 3, 1188-1194, September 1999
Laboratoire de Neurobiologie et Pharmacologie Cardiovasculaire,
Centre National de la Recherche Scientifique, Faculté de
Médecine, Université Louis Pasteur, Strasbourg, France
Central glutamatergic relays are known to be present in the central
sympathetic pathways. Ifenprodil (an
N-methyl-D-aspartate antagonist) and
baclofen (a
-aminobutyric acidB agonist) are both
modulators of these synapses; we previously reported their ability to
reduce the cardiovascular responses induced by a central hypothalamic
stimulation in rabbits. In this work, we investigated the actions of
chronic treatments with these two drugs on the increase of myocardial
oxygen demand induced by exercise in normotensive rats. Moreover, their
effects on the baroreceptor heart rate reflex were observed. Male
normotensive WKY rats were treated with placebo (two groups), baclofen,
or ifenprodil for 14 days. They were then submitted to a
progressively increased exercise test on a treadmill. In another three
groups of animals, the same treatment was applied but, at the end, a
baroreflex study was performed by the injection of phenylephrine (vagal
component of the reflex) and of sodium nitroprusside (sympathetic
component). Ifenprodil and baclofen reduced by nearly 50% the level of
the increase of the rate × pressure product during exercise as
compared with control rats. This effect appeared to be mainly due to a
reduction of the hypertensive response. In the same conditions, neither
baclofen nor ifenprodil significantly altered the baroreceptor heart
rate reflex. The fact that these two drugs are capable of reducing the
myocardial oxygen demand encourages us to test them in a model of
myocardial ischemia associated with sympathetic hyperactivity.